TrianglePUBLICATIONS · 33909449
Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2021 Jul 10
- First author
- Kumar A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kumar A
- type
- Author
- name
- Casulo C
- type
- Author
- name
- Advani RH
- type
- Author
- name
- Budde E
- type
- Author
- name
- Barr PM
- type
- Author
- name
- Batlevi CL
- type
- Author
- name
- Caron P
- type
- Author
- name
- Constine LS
- type
- Author
- name
- Dandapani SV
- type
- Author
- name
- Drill E
- type
- Author
- name
- Drullinsky P
- type
- Author
- name
- Friedberg JW
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kumar A
- type
- Author
- name
- Casulo C
- type
- Author
- name
- Advani RH
- type
- Author
- name
- Budde E
- type
- Author
- name
- Barr PM
- type
- Author
- name
- Batlevi CL
- type
- Author
- name
- Caron P
- type
- Author
- name
- Constine LS
- type
- Author
- name
- Dandapani SV
- type
- Author
- name
- Drill E
- type
- Author
- name
- Drullinsky P
- type
- Author
- name
- Friedberg JW
- type
- Author
- bibliography ids
- nci-bib-eea8133eef72b98eb82e3e85
- book metadata
- content sha256
- 81fae2aa48f1ee32d818fb11fa9b42c9b4deb9c13e4c9a3932d26c4991ad9dc0
- document type
- citation
- dois
- 10.1200/JCO.21.00108
- electronic publication date
- display
- 2021 Apr 28
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:33909449
- immutable id
- pubmed:33909449@81fae2aa48f1ee32d818fb11fa9b42c9b4deb9c13e4c9a3932d26c4991ad9dc0
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 20
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2257-2265
- volume
- 39
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 33909449
- provenance
- batch id
- 79f1021053e858d13ff3
- provider
- NCBI PubMed ESummary
- record sha256
- 2f0ee3e60ab5c2aa92214c354c370b8804009aea3968c61998bf7128d6beb927
- response sha256
- 671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
- retrieved at
- 2026-09-09T23:47:59.098265+00:00
- publication date
- display
- 2021 Jul 10
- precision
- day
- year
- 2021
- publication types
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.
Preserved source evidence · Not medical advice